A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy
Xiamen University · National University of Singapore
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
334
total citations
- FWCI
- 26.41
- Percentile
- 100%
- References
- 46
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Immunotherapy
- Cancer immunotherapy
- Antigen
- Antigen presentation
- Immune system
- Immunology
- Cytotoxic T cell
- Antigen-presenting cell
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- NUNational University of SingaporeAwards: NUHSRO/2021/034/TRP/09/Nanomedicine, NUHSRO/2021/034/TRP/09/, NUHSRO/2020/133/ Startup/08
- NNNational Natural Science Foundation of ChinaAwards: U1705281, 81925019, 81925019, 81422023, and U1705281, 81422023, and U1705281, NCET-13
- CPChina Postdoctoral Science FoundationAward: 2021M700115
- MSMajor State Basic Research Development Program of ChinaAward: 2017YFA0205201
- PFProgram for New Century Excellent Talents in UniversityAwards: NCET-13-0502, NCET-13, 13-0502, NCET-13-
- PRPostdoctoral Research Foundation of ChinaAward: 2021M702738 and 2021M700115
- FRFundamental Research Funds for the Central UniversitiesAwards: 20720200019, 20720190088